Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Cutting-Edge Areas of Immunology are Reviewed by Leading Researchers in New Volume from the New York Academy of Sciences

The Annals of the New York Academy of Sciences has released "The Year in Immunology."

Published February 01, 2010


Several novel approaches to understanding the mechanisms of immune regulation are reviewed in a new volume of the Annals of the New York Academy of Sciences, published by Wiley-Blackwell.

"The Year in Immunology 2," Annals volume 1183, January 2010, includes 18 reviews by leading experts in immunology covering a wide range of emerging research, including lineage determination of T cells; roles of various receptors in B cell activation; activation of plasmactyoid dendritic cells; microRNAs in inflammation and immunity; and autoimmune disorders. The first volume of the "Year in Immunology" series was published in November, 2008.


The volume's editor Dr. Noel R. Rose, a pioneer in the field of autoimmunity and autoimmune disease and Professor and Director of the Center for Autoimmune Disease Research at Johns Hopkins University, writes: "As our recognition of the potential dangers of an uncontrolled immune response has mounted, so has the need to better define the mechanisms of normal immune regulation that prevent an unbridled response. In 2009, our understanding of immunoregulatory mechanisms has both deepened and broadened." Rose adds that, "By a combination of fundamental, translational, and clinical research, 2009 has been a year when the borders of immunology have extended into new and sometimes unexpected fields." Of particular interest are new overviews of progress in our understanding how the immune system is regulated by environmental factors, such as the dioxin receptor, and by cellular regulatory mechanisms such as microRNAs.

Members of the media may obtain copies of the volume or online access by contacting Douglas Braaten, PhD, Director and Executive Editor, the Annals of the New York Academy of Sciences, at, or (212) 298-8634.

About the Annals of the New York Academy of Sciences
Continuously published since 1823, the Annals of the New York Academy of Sciences is the Academy's premier scholarly publication, offering proceedings of Academy and other scientific conferences, annual reviews in key disciplines, and selected topical collections. Published 32 volumes a year, the Annals provides cross-disciplinary perspectives on research for both the broad scientific community and the society at large. Although primarily focused in biomedicine and biology, the Annals' scope extends to fields such as astronomy, psychology, anthropology, and philosophy. Each volume presents a comprehensive treatment of each field of investigation at a time when emerging developments offer the promise of new insight. These volumes stimulate new ways to think about science by providing a neutral forum for discourse within and across many institutions and fields.

About the New York Academy of Sciences
Founded in 1817, the New York Academy of Sciences (NYAS) is an independent, nonprofit organization committed to advancing science, technology, and society worldwide. With about 24,000 members in 140 countries, NYAS is creating a global community of science for the benefit of humanity. NYAS' core mission is to advance scientific knowledge, positively impact the major global challenges of society with science-based solutions, and increase the number of scientifically informed individuals in society at large.

About Wiley-Blackwell
Wiley-Blackwell is the international scientific, technical, medical and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world’s leading societies. Wiley-Blackwell publishes over 1,400 peer-reviewed journals as well as 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit or